Page 6,519«..1020..6,5186,5196,5206,521..6,5306,540..»

Non-Doctor Pleads Not Guilty Of Manslaughter By Penis Enhancement

Posted: Published on September 12th, 2012

Illegal plastic surgery can not only lead to terrible results, it can also be fatalas one young man tragically discovered last year. But is that the fault of the "doctor?" Earlier today 35-year-old Kasia Rivera pleaded not guilty in the 2011 death of 22-year-old Justin Street. According to the medical examiner, Street died of a silicone embolism after Rivera performed a penis enlargement procedure on him in her home. On May 5, 2011, Riverawho has no medical training but seems to have been injected a few times herselfallegedly shot silicone directly into Street's bloodstream in an effort to make the young father of two's sex organ bigger. The procedure, performed in Rivera's home, didn't work. Instead it shut down the young man's organs, quickly killing him. In December his death was ruled a homicide and now Rivera, who is out on $75,000 bail, faces up to 10 years in prison if found guilty of second-degree reckless manslaughter. "The state is not alleging at all that she purposely caused his death, but that her behavior, her acting with no training, no preparation led to his death." Essex County Assistant Prosecutor William Neafsey explained after the hearing today. "Performing this type of … Continue reading →

Posted in Penis Enlargement | Comments Off on Non-Doctor Pleads Not Guilty Of Manslaughter By Penis Enhancement

NJ Woman Denies Causing Penis Injection Death

Posted: Published on September 12th, 2012

A New Jersey woman pleaded not guilty Tuesday to causing a man's death with an injection of silicone he hoped would enlarge his penis a procedure experts cautioned doesn't work. Kasia Rivera, 35, could face up to ten years in prison if convicted of reckless manslaughter in the death of 22-year-old Justin Street. Street, a father of two, had gone to Rivera on May 5 seeking a penile enlargement procedure, which prosecutors say Rivera advertised for in fliers posted at local businesses. Rivera, who performed the procedures in her apartment, allegedly with no medical license or training, administered a silicone shot to Street's penis, according to prosecutors. Street died the next day. His death was ruled a homicide following an investigation and a medical examiner's determination that he died of a silicone embolism. Rivera was indicted by a grand jury last month. Investigators believe Rivera may have conducted similar unauthorized procedures out of her East Orange apartment, but prosecutors said a search for witnesses, and a public plea for people to step forward, had not yielded any other clients to date. Rivera, who remains free on $75,000 bail, declined to comment through her court-appointed attorney Tuesday. Both Rivera and Street … Continue reading →

Posted in Penis Enlargement | Comments Off on NJ Woman Denies Causing Penis Injection Death

Stem cell researchers use gene therapy to restore immune systems in ‘Bubble Boy’ disease

Posted: Published on September 12th, 2012

ScienceDaily (Sep. 11, 2012) UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called "Bubble Boy" disease, a life threatening condition that if left untreated can be fatal within one to two years. In the 11-year study, researchers were able to test two therapy regimens for 10 children with ADA-deficient severe combined immunodeficiency (SCID). During the study, they refined their approach to include a light dose of chemotherapy to help remove many of the blood stem cells in the bone marrow that are not creating an enzyme called adenosine deaminase (ADA), which is critical for the production and survival of healthy white blood cells, said study senior Dr. Donald Kohn, a professor of pediatrics and of microbiology, immunology, and molecular genetics in Life Sciences and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. The refined gene therapy and chemotherapy regimen proved superior to the other method tested in the study, restoring immune function to three of the six children who received it, Kohn said. Going forward, an even further refined regimen using a different type of virus delivery system will … Continue reading →

Posted in Cell Therapy | Comments Off on Stem cell researchers use gene therapy to restore immune systems in ‘Bubble Boy’ disease

UCLA stem cell researchers use gene therapy to restore immune systems in ‘bubble babies’

Posted: Published on September 12th, 2012

Public release date: 11-Sep-2012 [ | E-mail | Share ] Contact: Kim Irwin kirwin@mednet.ucla.edu 310-435-9457 University of California - Los Angeles Health Sciences UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called "Bubble Boy" disease, a life threatening condition that if left untreated can be fatal within one to two years. In the 11-year study, researchers were able to test two therapy regimens for 10 children with ADA-deficient severe combined immunodeficiency (SCID). During the study, they refined their approach to include a light dose of chemotherapy to help remove many of the blood stem cells in the bone marrow that are not creating an enzyme called adenosine deaminase (ADA), which is critical for the production and survival of healthy white blood cells, said study senior Dr. Donald Kohn, a professor of pediatrics and of microbiology, immunology, and molecular genetics in Life Sciences and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. The refined gene therapy and chemotherapy regimen proved superior to the other method tested in the study, restoring immune function to three of the six children who received … Continue reading →

Posted in Cell Therapy | Comments Off on UCLA stem cell researchers use gene therapy to restore immune systems in ‘bubble babies’

Stem cell researchers use gene therapy to restore immune systems in 'Bubble Boy' disease

Posted: Published on September 12th, 2012

ScienceDaily (Sep. 11, 2012) UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called "Bubble Boy" disease, a life threatening condition that if left untreated can be fatal within one to two years. In the 11-year study, researchers were able to test two therapy regimens for 10 children with ADA-deficient severe combined immunodeficiency (SCID). During the study, they refined their approach to include a light dose of chemotherapy to help remove many of the blood stem cells in the bone marrow that are not creating an enzyme called adenosine deaminase (ADA), which is critical for the production and survival of healthy white blood cells, said study senior Dr. Donald Kohn, a professor of pediatrics and of microbiology, immunology, and molecular genetics in Life Sciences and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. The refined gene therapy and chemotherapy regimen proved superior to the other method tested in the study, restoring immune function to three of the six children who received it, Kohn said. Going forward, an even further refined regimen using a different type of virus delivery system will … Continue reading →

Posted in Cell Therapy | Comments Off on Stem cell researchers use gene therapy to restore immune systems in 'Bubble Boy' disease

UCLA stem cell researchers use gene therapy to restore immune systems in 'bubble babies'

Posted: Published on September 12th, 2012

Public release date: 11-Sep-2012 [ | E-mail | Share ] Contact: Kim Irwin kirwin@mednet.ucla.edu 310-435-9457 University of California - Los Angeles Health Sciences UCLA stem cell researchers have found that a gene therapy regimen can safely restore immune systems to children with so-called "Bubble Boy" disease, a life threatening condition that if left untreated can be fatal within one to two years. In the 11-year study, researchers were able to test two therapy regimens for 10 children with ADA-deficient severe combined immunodeficiency (SCID). During the study, they refined their approach to include a light dose of chemotherapy to help remove many of the blood stem cells in the bone marrow that are not creating an enzyme called adenosine deaminase (ADA), which is critical for the production and survival of healthy white blood cells, said study senior Dr. Donald Kohn, a professor of pediatrics and of microbiology, immunology, and molecular genetics in Life Sciences and a member of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA. The refined gene therapy and chemotherapy regimen proved superior to the other method tested in the study, restoring immune function to three of the six children who received … Continue reading →

Posted in Cell Therapy | Comments Off on UCLA stem cell researchers use gene therapy to restore immune systems in 'bubble babies'

UPDATE 1-Failed Alzheimer's drug showed signs of working-studies

Posted: Published on September 12th, 2012

* Significantly cut levels of Alzheimer's related proteins * Findings suggest drug may work in earlier-stage disease * Dose, side effects may be an issue (Adds analyst's, expert's comments, background) By Julie Steenhuysen CHICAGO, Sept 11 (Reuters) - New data on Pfizer Inc and Johnson & Johnson (TLO: JNJ-U.TI - news) 's Alzheimer's drug, bapineuzumab, show the treatment reduced underlying markers of the disease in some patients, suggesting the failed medication might work at an earlier stage. The findings from two large studies, presented at a European neurology meeting in Stockholm on Tuesday, followed the companies' announcement last month that they were scrapping large-scale clinical trials of the drug after it failed to improve memory or thinking skills in patients with mild to moderate Alzheimer's. Many researchers had expected bapineuzumab to fail this test because they believe that Alzheimer's starts years before memory problems become apparent, and that treatment when patients already have dementia may be too late. But they have been eagerly awaiting the so-called biomarker results, which measure fluids and tissues in the body, to see if the drug hit its biological targets and therefore, could work at an earlier stage of the disease. The biomarker results show … Continue reading →

Posted in Drug Side Effects | Comments Off on UPDATE 1-Failed Alzheimer's drug showed signs of working-studies

Diet could combat adverse side-effects of quinine

Posted: Published on September 12th, 2012

Public release date: 11-Sep-2012 [ | E-mail | Share ] Contact: Lindsay Brooke lindsay.brooke@nottingham.ac.uk 44-011-595-15751 University of Nottingham Scientists at The University of Nottingham say adverse side-effects caused by the anti-parasitic drug quinine in the treatment of malaria could be controlled by what we eat. The research, carried out by Nottingham scientists on the University's campuses in the UK and Malaysia, indicates that natural variation in our levels of the amino acid, tryptophan, has a marked bearing on how we respond to quinine treatment. It appears that the lower our levels of tryptophan the more likely it is that we would suffer side-effects. And because tryptophan is an essential amino acid the body cannot produce it we get it from the food we eat. Discovered back in the 1600s, quinine is still used for anti-malaria treatment. However, it is associated with a long list of side effects ranging from sickness and headaches to blindness, deafness and in rare cases death. This latest study, published in the Journal of Antimicrobial Chemotherapy, could offer a cheap and simple way of combating our adverse reaction to quinine treatment and improving the performance of this important drug. The study, funded by The University of … Continue reading →

Posted in Drug Side Effects | Comments Off on Diet could combat adverse side-effects of quinine

Diet could combat adverse side-effects of anti-parasitic drug quinine

Posted: Published on September 12th, 2012

ScienceDaily (Sep. 11, 2012) Scientists at The University of Nottingham say adverse side-effects caused by the anti-parasitic drug quinine in the treatment of malaria could be controlled by what we eat. The research, carried out by Nottingham scientists on the University's campuses in the UK and Malaysia, indicates that natural variation in our levels of the amino acid, tryptophan, has a marked bearing on how we respond to quinine treatment. It appears that the lower our levels of tryptophan the more likely it is that we would suffer side-effects. And because tryptophan is an essential amino acid the body cannot produce it -- we get it from the food we eat. Discovered back in the 1600s, quinine is still used for anti-malaria treatment. However, it is associated with a long list of side effects ranging from sickness and headaches to blindness, deafness and in rare cases death. This latest study, published in the Journal of Antimicrobial Chemotherapy, could offer a cheap and simple way of combating our adverse reaction to quinine treatment and improving the performance of this important drug. The study, funded by The University of Nottingham's doctoral award scheme, was led by Dr Simon Avery and Dr Kang-Nee … Continue reading →

Posted in Drug Side Effects | Comments Off on Diet could combat adverse side-effects of anti-parasitic drug quinine

Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets Recall

Posted: Published on September 12th, 2012

Some tablets exceed the weight specification and could be super-potent for the ingredients Hydrocodone Bitartrate and Acetaminophen. The recall includes the following product lot: Hydrocodone Bitartrate and Acetaminophen Tablets, USP 10 mg/500 mg, NDC 0603-3888-21, 100 count, Lot Number C1440512A, expiry date 12/13. It is possible that some tablets from lot C1440512A exceed the weight specification and could be super-potent for the ingredients Hydrocodone Bitartrate and Acetaminophen. Bottles from the affected lot may contain tablets that have a higher dosage of acetaminophen, and as a result, it is possible that consumers could take more than the intended acetaminophen dose. Unintentional administration of tablets with increased acetaminophen content could result in liver toxicity, especially in patients on other acetaminophen containing medications, patients with liver dysfunction, or people who consume more than 3 alcoholic beverages a day. The product label warns consumers that acetaminophen overdose can potentially cause severe liver damage, at times resulting in liver transplant or death. Taking a higher dose of hydrocodone than intended could result in an increase in the severity or frequency of side effects, such as sedation or respiratory depression, particularly in patients who are elderly, have severe kidney or liver impairment, or are also taking … Continue reading →

Posted in Wholesale Pharmacy | Comments Off on Qualitest Hydrocodone Bitartrate and Acetaminophen Tablets Recall

Page 6,519«..1020..6,5186,5196,5206,521..6,5306,540..»